George Hu

Long-term Tumor Regression Induced by an Antibody–Drug Conjugate That Targets 5T4, an Oncofetal Antigen Expressed on Tumor-Initiating Cells

Puja Sapra, Marc Damelin, John F. DiJoseph et al. · Molecular Cancer Therapeutics · 2012 · 79 citations · Full text

Medicine, Oncology, Pharmacology +17

PF-06804103, A Site-specific Anti-HER2 Antibody–Drug Conjugate for the Treatment of HER2-expressing Breast, Gastric, and Lung Cancers

Edmund I. Graziani, Matthew Sung, Dangshe Ma et al. · Molecular Cancer Therapeutics · 2020 · 48 citations

Pharmacy, Medicinal Chemistry, Oncology +17

Demonstration of the preclinical correlate of protection for Staphylococcus aureus clumping factor A in a murine model of infection

Ingrid L. Scully, Yekaterina Timofeyeva, David Keeney et al. · Vaccine · 2015 · 41 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

CJ-13610, an orally active inhibitor of 5-lipoxygenase is efficacious in preclinical models of pain

Luz Cortes-Burgos, Ben S. Zweifel, Steven L. Settle et al. · European Journal of Pharmacology · 2009 · 36 citations

Medicine, Medicinal Chemistry, Pharmacology +10

Novel Tight-Binding Inhibitory Factor-κB Kinase (IKK-2) Inhibitors Demonstrate Target-Specific Anti-Inflammatory Activities in Cellular Assays and following Oral and Local Delivery in an in Vivo Model of Airway Inflammation

Cynthia D. Sommers, Janice Thompson, Julia A. Guzova et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 33 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16